198 related articles for article (PubMed ID: 36703130)
21. Mdm2 is a target and mediator of IRP2 in cell growth control.
Zhang J; Kong X; Zhang Y; Sun W; Xu E; Chen X
FASEB J; 2020 Feb; 34(2):2301-2311. PubMed ID: 31907996
[TBL] [Abstract][Full Text] [Related]
22. The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.
Kamihara Y; Takada K; Sato T; Kawano Y; Murase K; Arihara Y; Kikuchi S; Hayasaka N; Usami M; Iyama S; Miyanishi K; Sato Y; Kobune M; Kato J
Oncotarget; 2016 Sep; 7(39):64330-64341. PubMed ID: 27602957
[TBL] [Abstract][Full Text] [Related]
23. Involvement of heme in the degradation of iron-regulatory protein 2.
Goessling LS; Mascotti DP; Thach RE
J Biol Chem; 1998 May; 273(20):12555-7. PubMed ID: 9575215
[TBL] [Abstract][Full Text] [Related]
24. Cysteine oxidation regulates the RNA-binding activity of iron regulatory protein 2.
Zumbrennen KB; Wallander ML; Romney SJ; Leibold EA
Mol Cell Biol; 2009 Apr; 29(8):2219-29. PubMed ID: 19223469
[TBL] [Abstract][Full Text] [Related]
25. Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia.
Li K; Besse EK; Ha D; Kovtunovych G; Rouault TA
Hum Mol Genet; 2008 Aug; 17(15):2265-73. PubMed ID: 18424449
[TBL] [Abstract][Full Text] [Related]
26. Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178.
Wang J; Fillebeen C; Chen G; Andriopoulos B; Pantopoulos K
Mol Cell Biol; 2006 Mar; 26(5):1948-54. PubMed ID: 16479012
[TBL] [Abstract][Full Text] [Related]
27. The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2.
Bourdon E; Kang DK; Ghosh MC; Drake SK; Wey J; Levine RL; Rouault TA
Blood Cells Mol Dis; 2003; 31(2):247-55. PubMed ID: 12972033
[TBL] [Abstract][Full Text] [Related]
28. Irp2 Knockout Causes Osteoporosis by Inhibition of Bone Remodeling.
Zhou Y; Yang Y; Liu Y; Chang H; Liu K; Zhang X; Chang Y
Calcif Tissue Int; 2019 Jan; 104(1):70-78. PubMed ID: 30191282
[TBL] [Abstract][Full Text] [Related]
29. Iron overload induced by IRP2 gene knockout aggravates symptoms of Parkinson's disease.
Ci YZ; Li H; You LH; Jin Y; Zhou R; Gao G; Hoi MPM; Wang C; Chang YZ; Yu P
Neurochem Int; 2020 Mar; 134():104657. PubMed ID: 31904393
[TBL] [Abstract][Full Text] [Related]
30. Excess capacity of the iron regulatory protein system.
Wang W; Di X; D'Agostino RB; Torti SV; Torti FM
J Biol Chem; 2007 Aug; 282(34):24650-9. PubMed ID: 17604281
[TBL] [Abstract][Full Text] [Related]
31. Iron-dependent degradation of IRP2 requires its C-terminal region and IRP structural integrity.
Wang J; Chen G; Lee J; Pantopoulos K
BMC Mol Biol; 2008 Jan; 9():15. PubMed ID: 18226225
[TBL] [Abstract][Full Text] [Related]
32. The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL.
Wang J; Pantopoulos K
Biochim Biophys Acta; 2005 Mar; 1743(1-2):79-85. PubMed ID: 15777842
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer.
Liu F; Gai X; Wu Y; Zhang B; Wu X; Cheng R; Tang B; Shang K; Zhao N; Deng W; Chen J; Zhang Z; Gu S; Zheng L; Zhang H
Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2202157119. PubMed ID: 36122209
[No Abstract] [Full Text] [Related]
34. Cell-autonomous and systemic context-dependent functions of iron regulatory protein 2 in mammalian iron metabolism.
Ferring-Appel D; Hentze MW; Galy B
Blood; 2009 Jan; 113(3):679-87. PubMed ID: 18922858
[TBL] [Abstract][Full Text] [Related]
35. Oxygen and iron regulation of iron regulatory protein 2.
Hanson ES; Rawlins ML; Leibold EA
J Biol Chem; 2003 Oct; 278(41):40337-42. PubMed ID: 12888568
[TBL] [Abstract][Full Text] [Related]
36. Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells.
Alberghini A; Recalcati S; Tacchini L; Santambrogio P; Campanella A; Cairo G
J Biol Chem; 2005 Aug; 280(34):30120-8. PubMed ID: 15985433
[TBL] [Abstract][Full Text] [Related]
37. Deubiquitylase OTUD3 prevents Parkinson's disease through stabilizing iron regulatory protein 2.
Jia F; Li H; Jiao Q; Li C; Fu L; Cui C; Jiang H; Zhang L
Cell Death Dis; 2022 Apr; 13(4):418. PubMed ID: 35490179
[TBL] [Abstract][Full Text] [Related]
38. Iron regulatory protein 2 in ovarian endometrial cysts.
Takenaka M; Suzuki N; Mori M; Hirayama T; Nagasawa H; Morishige KI
Biochem Biophys Res Commun; 2017 Jun; 487(4):789-794. PubMed ID: 28450115
[TBL] [Abstract][Full Text] [Related]
39. Redox control of iron regulatory protein 2 stability.
Hausmann A; Lee J; Pantopoulos K
FEBS Lett; 2011 Feb; 585(4):687-92. PubMed ID: 21281640
[TBL] [Abstract][Full Text] [Related]
40. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2.
Yamanaka K; Ishikawa H; Megumi Y; Tokunaga F; Kanie M; Rouault TA; Morishima I; Minato N; Ishimori K; Iwai K
Nat Cell Biol; 2003 Apr; 5(4):336-40. PubMed ID: 12629548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
